Bentrio
Back to BentrioLegal

Imprint

Information pursuant to Art. 3 UWG and applicable EU disclosure requirements

This website is operated and published by Altamira Medica AG, a Swiss medical device company headquartered in Basel, Switzerland. The information set out below is provided in accordance with Article 3 paragraph 1 letter s of the Swiss Federal Act against Unfair Competition (UWG) and, where applicable, the disclosure requirements of the European Union.

Publisher

Altamira Medica AGPeter Merian-Strasse 904052 BaselSwitzerland

Contact

General
service@bentrio.com
Quality & vigilance
qa@altamiramedica.com
Data protection
dataprotection@altamiramedica.com
Phone
+41 79 969 96 60

Company details

Legal form
Aktiengesellschaft (AG) under Swiss law
Commercial register
Handelsregister des Kantons Basel-Stadt
UID / register no.
CHE-393.487.262
VAT no.
CHE-393.487.262 MWST

Authorised representatives: the members of the Board of Directors and the Management as registered with the Commercial Register of the Canton of Basel-Stadt.

EU representative

For matters relating to the General Data Protection Regulation (GDPR) and EU-facing inquiries, the appointed EU representative of Altamira Medica AG is:

Altamira Medica Ltd.The Black Church, St. Mary’s PlaceDublin D07 P4AXIreland

Regulatory information

Bentrio® is a Class IIa medical device CE-marked under Regulation (EU) 2017/745 on Medical Devices (EU MDR). The Notified Body is identified by number 2797. The product is intended for use in accordance with its instructions for use; please read the package leaflet or consult a healthcare professional before use.

For product complaints, vigilance reports or quality questions, please contact qa@altamiramedica.com. Suspected serious incidents involving a medical device should also be reported to your national competent authority.

Online dispute resolution

The European Commission provides a platform for online dispute resolution (ODR) at ec.europa.eu/consumers/odr. Altamira Medica AG is neither obligated nor willing to participate in dispute resolution proceedings before a consumer arbitration board.

More legal information